CoChat

Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

The lung is a complex organ; it is both the initial barrier for inhaled agents and the site of metabolism and therapeutic effect for a subset of systemically administered drugs. Comprised of more than 40 cell types that are responsible for various important functions, the lung's complexity contributes to the subsequent challenges in developing complex in vitro co-culture models (also called microphysiological systems (MPS), complex in vitro models or organs-on-a-chip). Although there are multiple considerations and limitations in the development and qualification of such in vitro systems, MPS exhibit great promise in the fields of pharmacology and toxicology. Successful development and implementation of MPS models may enable mechanistic bridging between non-clinical species and humans, and increase clinical relevance of safety endpoints, while decreasing overall animal use. This article summarizes, from a biopharmaceutical industry perspective, essential elements for the development and qualification of lung MPS models. Its purpose is to guide MPS developers and manufacturers to expedite MPS utilization for safety assessment in the biopharmaceutical industry.

Overview

Integrity signals

Registry

Crossref · 10.1039/c9lc00492k

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Research works printed but not linked: 4

  1. Marx, 2016, ALTEX, 33, 272
  2. N. Sachs , D. D. Z.Ommen , A.Papaspyropoulos , I.Heo , L.Bottinger , D.Klay , F.Weeber , G.Huelsz-Prince , N.Iakobachvili , M. C.Viveen , A.Lyubimova , L.Teeven , S.Derakhshan , J.Korving , H.Begthel , K.Kumawat , E.Ramos , M. F. M.van Oosterhout , E. P.Olimpio , J.de Ligt , K. K.Dijkstra , E. F.Smit , M.van der Linden , E. E.Voest , C. H. M.van Moorsel , C. K.van der Ent , E.Cuppen , A.van Oudenaarden , F. E.Coenjaerts , L.Meyaard , L. J.Bont , P. J.Peters , S. J.Tans , J. S.van Zon , S. F.Boj , R. G.Vries , J. M.Beekman and H.Clevers , bioRxiv, 2018 , p. 318444
  3. Ralston, 2017, Toxicologist, 150, 312
  4. Fagan, 2011, US Pharm., 36, HS3

Cited by

See all 65

Metadata

Authors
Ainslie, G. R., Davis, M., Ewart, L., Lieberman, L. A., Rowlands, D. J., Thorley, A. J., Yoder, G., & Ryan, A. M.
Affiliations
  • Theravance Biopharma (United States) (US)
  • Princeton University (US)
  • AstraZeneca (United Kingdom) (GB)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • Novartis (Switzerland) (CH)
  • Janssen (Belgium) (BE)
  • Pfizer (United States) (US)
Corresponding author
Ainslie, Garrett R.
Venue
Lab on a Chip
Published
2019
Volume
19
Issue
19
Pages
3152-3161
ISSN
  • 1473-0189 (ISSN-L)
  • 1473-0197
OpenAlex
W2970730415
Cited by
65
References
33
Citations by year
2026: 1 · 2025: 7 · 2024: 8 · 2023: 15 · 2022: 9 · 2021: 15 · 2020: 10
FWCI
0.69
Type
journal article
Language
en
Open access
closed
Locations
  • Lab on a Chip (publishedVersion)
  • PubMed (publishedVersion)
Funders
Novartis Institutes for BioMedical Research
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
microphysiological systems, lung-on-a-chip, in vitro co-culture model, drug safety assessment, toxicology, model qualification, animal use reduction, biopharmaceutical development
MeSH terms
Humans, Lung, Models, Biological, Coculture Techniques, Microfluidic Analytical Techniques, Lab-On-A-Chip Devices

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective. https://app.cochat.ai/papers/10.1039/c9lc00492k
The paper
Ainslie, G. R., Davis, M., Ewart, L., Lieberman, L. A., Rowlands, D. J., Thorley, A. J., Yoder, G., & Ryan, A. M. (2019). Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective. Lab on a Chip. https://doi.org/10.1039/c9lc00492k

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.